O.P. Amcop SRL
Active in EUDAMEDItalyfrom EUDAMED address EUDAMED SRN IT-MF-000025112
- Devices
- 0
- Registrations
- EUDAMED
At a glance
Market reach
- European Union
- EUDAMED actor
Company details
- EUDAMED SRN
- IT-MF-000025112
- EU VAT number
- 08265940729
- EUDAMED status
- Active
- EUDAMED registered name
- O.P. AMCOP SRL
- EUDAMED abbreviated name
- O.P. AMCOP
- Website
- www.amcop.it
- facebook.com/bioattivatoriamcop
- [email protected]
- Phone
- 3337491192
- PRRC contact
- FRANCESCO MAGISTRO
From the company website
The final goal of the patent enhancement project no. 102015000057082, granted to O.P. Amcop S.r.l. on 31/05/2018, entitled “Orthodontic-elastic-harmonic-facial device” is to achieve the development of the prototype and the production of the product subject to the patent and to verify that the innovations conceived in the laboratory guarantee the benefits sought in terms of restoration of the architecture of the bone structures of the cranio-facial-mandibular system. To reach the goal it has decided to follow a path so composed: 1) Technical feasibility study: a. starting from the recognized claims of the patent, the congruence of the objectives will be verified with the current trends and dynamics of the market; b. a prior reconnaissance of the materials – current and potential – of the production processes, as well as the types of developable liner. The aim is, evidently, to select the best techniques and processes in origin and that better adapt to the concrete valorisation of the patent, avoiding unnecessary and costly losses of time. 2) Production design: chosen materials and production processes will move to executive design, also selecting the necessary equipment and designing selected models 3) Ingegnerization: pre-industrial level will be studied the specifics of the selected models in order to favor the production of preserie 4) Prototyping 5) Pre-series production Pre-series production, therefore, will allow to immediately carry out a market test through the consolidated sales channels of the company, both direct (dental studies and laboratories) and indirect (official distributor). At the same time it will be given the possibility to determine with greater detail the economic - financial aspects such as production costs, break even point, marketing price and consequent profit margins.